Skip to content
Search

Latest Stories

GPhC forms Anti-Racism Champions to promote inclusivity in pharmacy

GPhC forms Anti-Racism Champions to promote inclusivity in pharmacy

Pharmacy professionals continue to experience discrimination and racism in practice, even at the most senior levels

The General Pharmaceutical Council (GPhC) has taken a significant step towards advancing its anti-racism agenda by forming a new working group of "Anti-Racism Champions."

Comprising existing GPhC Council and Executive members, the group is committed to providing visible and vocal leadership, internally and externally, to combat racism and promote inclusivity across the pharmacy sector.


The formation of this working group follows the GPhC's recent Governing Council discussion in July, which focused on the next steps in its ‘Racism in Pharmacy’ work.

This initiative is an important part of the GPhC's wider Equality, Diversity, and Inclusion (EDI) strategy, aimed at proactively addressing discrimination and reducing health inequalities through the Council's regulatory influence.

The Anti-Racism Champions group includes people with lived experience of racism and allies who will help shape future action.

The group members are:

  • Gisela Abbam, Chair of Council
  • Ade Williams, pharmacist member of Council
  • Ann Jacklin, pharmacist member of Council
  • Gareth Powell, lay member of Council
  • Dionne Spence, Chief Enforcement Officer and Deputy Registrar
  • Louise Edwards, Chief Strategy Officer and Deputy Registrar
  • Laura McClintock, Chief of Staff

The GPhC highlighted that pharmacy professionals continue to experience discrimination and racism in practice and throughout their careers, even at the most senior levels, noting that “We should all be determined to change this.”

“We want to promote and foster a workplace environment within the pharmacy profession where every individual feels valued, included, and empowered to contribute meaningfully, at all levels.

“The new group will help us drive forward our commitments in this area, holding ourselves to the same high standards we expect of others,” the regulator said.

The GPhC's next anti-racism efforts build on their earlier equality roundtables and associated reports.

The Council will be discussing our wider EDI work in public session in September, with an update on all of the activity completed in 2023/24 (Year 2) of our strategy.

The Council will further discuss its broader EDI work during a public session in September, where an update on all of the activity completed in 2023/24 (Year 2) of the strategy will be presented.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less